An article in The Lancet discussed a clinical trial of a product for a rare disease. The authors had modified the primary analysis from an unadjusted Wilcoxon rank sum test to a Poisson regression. This led to several questions including: Was a Poisson distribution appropriate? How were the covariates selected? What is the effect of outliers (there were some)? If the Poisson model is not appropriate, can a permutation test approach provide information regarding the effect of the treatment? The presentation will show how Stata was used to evaluate these assumptions and provide an alternative analysis. The implications of this analysis are discussed.
Download Info
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
page. Note that these files are not on the IDEAS
site. Please be patient as the files may be large.